Press release
Uterine Cancer Diagnostic Testing Market : Sales Volume Market Share by Type and Application ( 2017 – 2025)
Uterine cancer, commonly, is a form of cancer in female reproductive system which usually initiates in the tissues of uterus. The most common type of gynecologic cancer occurring worldwide is cervical cancer that arises from the lower portion of uterus, while the second most common cancer is endometrial cancer which initiates in endometrium, the lining of uterus. Endometrial cancer is the most common type of uterine cancer, commonly found in women going through menopause. Women with an average age of 60 years are the most likely to diagnose with endometrial cancer. As per the American Cancer Society, it has been anticipated that in 2017, about 61,380 new cases of uterus body cancer would be diagnosed in United States and around 10,920 women will die of uterine body cancer. Uterine body cancers include both uterine sarcomas and endometrial cancers. According to World Health Organization, developed regions such as North America followed by Europe registers greater incidence rate for endometrial uterine cancer owing to the changing lifestyle opted by women.Uterine cancer diagnostic testing is extremely important for women to keep themselves in good health conditions. In order to diagnose uterine cancer, a doctor carries out various diagnostic tests considering some of the factors such as stage and type of suspected cancer, age and medical condition of the patient, symptoms and results of prior medical tests if any. The most common types of tests performed by doctors to diagnose a uterine cancer involves: physical examination, imaging tests and surgical biopsy.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/17005
Growing awareness among women about uterine ailments coupled with availability of large number of diagnostic tests in market is expected to be the key factor driving the growth of uterine cancer diagnostic testing market. Growing healthcare expenditure and advancement in drug industry are some other factors propelling growth of uterine cancer diagnostic testing market.Performance of uterine cancer diagnostic testing market is primarily determined by increasing incidence rate of uterine diseases across the globe.However, adverse side effects caused by using highly toxic drugs and high cost of treatments are some of the factors restraining the market growth. Also, clinical trials on cancer drugs experience low success rate, which in turn is responsible for sluggish growth in uterine cancer diagnostic testing industry.
Among all test types, hysteroscopy is most commonly recommended uterine cancer diagnostic test. Endometrial biopsy is recommended as confirmatory test for diagnosis of uterine cancer and major part workforce in any histopathology laboratory is occupied with endometrial biopsies.
On the basis of geography, global uterine cancer diagnostic testing market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is projected to hold largest shares in the global market primarily due to growing incidence of uterine cancer among women and innovations in diagnostic techniques. Asia pacific uterine cancer diagnostic testing market is anticipated to witness prominent growth during the forecast period owing to increased healthcare expenditure in developing countries such as India and China.
Some of the key players present in global uterine cancer diagnostic testing market are Abbott Laboratories, Ariad Pharmaceuticals, Inc., Merck & Co., Inc., Becton, Dickinson & Co., Siemens Healthcare Inc., F. Hoffman-La Roche Ltd., GlaxoSmithKline Plc., etc.
To view complete report @ http://www.persistencemarketresearch.com/market-research/uterine-cancer-diagnostic-testing-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uterine Cancer Diagnostic Testing Market : Sales Volume Market Share by Type and Application ( 2017 – 2025) here
News-ID: 672205 • Views: …
More Releases from Persistence Market Research

Smart Door Lock Market Anticipated to Hit USD 9.89 Billion by 2032
The global smart door lock market is experiencing transformative growth as consumer demand for security, convenience, and smart home integration intensifies. The market size is projected to increase from US$ 3,059.7 Mn in 2025 to US$ 9,890.6 Mn by 2032, registering a robust CAGR of 18.3% during the forecast period. Rising concerns about home and workplace security, combined with rapid technological innovations, are fueling the adoption of smart door locks.…

Diisononyl Phthalate Market to Reach US$4.6 Bn by 2031 Driven by Rising Demand i …
The global Diisononyl Phthalate (DINP) market is undergoing a steady expansion, shaped by evolving industrial applications, regulatory dynamics, and technological innovations in plasticizers. As a key phthalate plasticizer, DINP is predominantly used in the production of flexible polyvinyl chloride (PVC) products. Its superior durability, flexibility, and resistance to weathering make it indispensable across a wide range of industries, from construction and automotive to consumer goods.
According to the latest study by…

Propylene Carbonate Market to Reach US$468.2 Mn by 2031, Driven by Rising Demand …
The global propylene carbonate market is entering a promising growth phase, fueled by rising demand across multiple industries, particularly in electronics, automotive, and paints & coatings. Propylene carbonate, a highly versatile organic compound, is widely recognized for its exceptional solvent properties, biodegradability, and low toxicity, making it a preferred choice in green chemistry applications.
According to the latest study by Persistence Market Research, the market is expected to grow from US$275.5…

Flexible Electronics Market Anticipated to Hit USD 5,880.6 Million by 2030
The Global Flexible Electronics Market is forecasted to expand at a CAGR of 11.4%, increasing from a value of US$ 2,762.0 million in 2023 to US$ 5,880.6 million by 2030. Flexible electronics is transforming the conventional electronics industry by integrating lightweight, bendable, and conformable devices into everyday life. These technologies are being widely adopted across consumer electronics, healthcare, automotive, and wearable technology sectors, promising increased portability, efficiency, and user-friendly designs.
Elevate…
More Releases for Uterine
Uterine Fibroids Symptoms
USA Fibroids Center is here to offer detailed information on https://www.usafibroidcenters.com/blog/uterine-fibroids-symptoms/ and help you discuss the best treatments for uterine fibroids at the clinic.
Find out the best Fibroid Treatment for you!
Treatments for uterine fibroids are accessed in women with problems related to them and show symptoms such as heavy menstrual bleeding, pain or pressure in the pelvis, or infertility and sterility.
…
Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroi …
Bharath Hospital Kottayam is excited introduce the latest advancement in women's healthcare - the Uterine Fibroid Embolization (UFE) treatment. Uterine fibroids are non-cancerous growths that form in the uterus. They are a common condition among women, especially those of reproductive age. These tumors can vary in size, from small growths to large masses that can distort the shape of the uterus. Although many women with uterine fibroids experience no symptoms,…
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players…
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape.
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers…
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort.
According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to…